Form 4: Edgewise Therapeutics Executive Sells Shares to Cover Tax Obligations
SEC Form 4 Filing
John R. Moore, General Counsel of Edgewise Therapeutics, sold shares to cover statutory tax withholding obligations related to vesting Restricted Stock Units.
Summary
- On May 1, 2024, John R. Moore, General Counsel of Edgewise Therapeutics, exercised 5,208 Restricted Stock Units (RSUs) which converted into common stock.
- Following the exercise, Moore sold 1,956 shares of common stock on May 2, 2024, at an average price of $18.91 per share, with prices ranging from $18.68 to $19.12.
- The sale was to cover statutory tax withholding obligations associated with the vesting of the RSUs.
- After the transactions, Moore directly owns 3,252 shares of Edgewise Therapeutics common stock and 5,209 derivative securities.
Sentiment
Score: 5
Explanation: This is a neutral event. An executive selling shares to cover taxes is a normal occurrence and doesn't necessarily reflect a positive or negative outlook on the company.
Industry Context
This is a routine Form 4 filing, reflecting the sale of shares by an executive to cover tax obligations. Such transactions are common and don't necessarily indicate a change in the executive's confidence in the company.
Key Dates
| Date | Description |
|---|---|
| 05/01/2023 | Beginning of three equal annual installments for RSU vesting. |
| 05/01/2024 | Exercise of 5,208 Restricted Stock Units (RSUs). |
| 05/02/2024 | Sale of 1,956 shares of common stock. |
| 05/03/2024 | Date of signature for the Form 4 filing. |
| 05/01/2032 | Expiration date of Restricted Stock Units. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.